Cargando…
Shenkang injection combined with alprostadil for chronic renal failure: A systematic review and meta-analysis
OBJECTIVE: To systematically evaluate the clinical efficacy and safety of Shenkang injection (SKI) combined with alprostadil in the treatment of chronic renal failure (CRF). METHOD: Randomized controlled trials (RCTs) of Shenkang injection combined with alprostadil in CRF treatment were investigated...
Autores principales: | Xie, Feng, Zhang, Tiantian, Zhang, Pu, Qu, Xinliang, Li, Min, Lan, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118024/ https://www.ncbi.nlm.nih.gov/pubmed/37089596 http://dx.doi.org/10.3389/fmed.2023.982016 |
Ejemplares similares
-
Protective effect and mechanism of Shenkang injection on adenine-induced chronic renal failure in rats
por: Chen, Rongchang, et al.
Publicado: (2022) -
Efficacy and safety of Shenkang injection in the treatment of chronic renal failure: A protocol of a randomized controlled trial
por: Mei, JuXiang, et al.
Publicado: (2021) -
Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology—Molecular docking—Key target validation"
por: Zhou, Lin, et al.
Publicado: (2023) -
Shenkang protects renal function in diabetic rats by preserving nephrin expression
por: Qu, Zhihui, et al.
Publicado: (2023) -
ShenKang Injection Attenuates Renal Fibrosis by Inhibiting EMT and Regulating the Wnt/β-Catenin Pathway
por: Wei, Hui-Ting, et al.
Publicado: (2022)